| 项目 血细胞成分 | 健康组 | 治疗后组 | ||
| N | ( ) | N | ( ) | |
| WBC (109/L) | 10 | 15.71 ± 4.84a | 15 | 13.06 ± 4.49a |
| LYM (%) | 10 | 50.17 ± 7.96a | 15 | 46.45 ± 14.42 |
| MID (%) | 10 | 15.79 ± 3.28a | 15 | 12.46 ± 3.90b |
| GRAN (%) | 10 | 26.04 ± 6.62a | 15 | 61.76 ± 76.75a |
| LYM (109/L) | 10 | 9.32 ± 3.40a | 15 | 5.85 ± 2.59a |
| MID (109/L) | 10 | 2.49 ± 1.00A | 15 | 1.56 ± 0.52B |
| GRAN (109/L) | 10 | 3.90 ± 1.30a | 15 | 5.58 ± 3.78a |
| RBC (1012/L) | 10 | 5.50 ± 1.18a | 15 | 5.47 ± 0.87a |
| HGB (g/L) | 10 | 106.40 ± 25.03a | 15 | 109.27 ± 16.31a |
| HCT (%) | 10 | 23.97 ± 5.87a | 15 | 28.33 ± 6.34a |
| MCV (fL) | 10 | 43.37 ± 1.93A | 15 | 50.59 ± 2.11B |
| MCH (pg) | 10 | 19.17 ± 1.69a | 15 | 20.04 ± 1.82a |
| MCHC (g/L) | 10 | 444.90 ± 50.30A | 15 | 398.80 ± 46.99B |
| RDW-SD (fL) | 10 | 24.15 ± 3.52A | 15 | 20.19 ± 2.08B |
| RDW-CV (%) | 10 | 15.07 ± 1.66A | 15 | 13.08 ± 0.96B |